- Home
- MIRA vs AQMS Comparison
MIRA vs AQMS Comparison
Compare MIRA & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRA
- AQMS
- Stock Information
- Founded
- MIRA 2020
- AQMS 2014
- Country
- MIRA United States
- AQMS United States
- Employees
- MIRA N/A
- AQMS N/A
- Industry
- MIRA Biotechnology: Pharmaceutical Preparations
- AQMS Metal Fabrications
- Sector
- MIRA Health Care
- AQMS Industrials
- Exchange
- MIRA Nasdaq
- AQMS Nasdaq
- Market Cap
- MIRA 21.2M
- AQMS 18.0M
- IPO Year
- MIRA 2023
- AQMS 2015
- Fundamental
- Price
- MIRA $1.09
- AQMS $1.95
- Analyst Decision
- MIRA Strong Buy
- AQMS Strong Buy
- Analyst Count
- MIRA 2
- AQMS 2
- Target Price
- MIRA $14.00
- AQMS $30.00
- AVG Volume (30 Days)
- MIRA 493.9K
- AQMS 147.5K
- Earning Date
- MIRA 11-12-2024
- AQMS 11-14-2024
- Dividend Yield
- MIRA N/A
- AQMS N/A
- EPS Growth
- MIRA N/A
- AQMS N/A
- EPS
- MIRA N/A
- AQMS N/A
- Revenue
- MIRA N/A
- AQMS N/A
- Revenue This Year
- MIRA N/A
- AQMS N/A
- Revenue Next Year
- MIRA N/A
- AQMS N/A
- P/E Ratio
- MIRA N/A
- AQMS N/A
- Revenue Growth
- MIRA N/A
- AQMS 525.00
- 52 Week Low
- MIRA $0.51
- AQMS $1.33
- 52 Week High
- MIRA $5.01
- AQMS $17.40
- Technical
- Relative Strength Index (RSI)
- MIRA 37.31
- AQMS 43.66
- Support Level
- MIRA $1.04
- AQMS $1.87
- Resistance Level
- MIRA $1.16
- AQMS $3.00
- Average True Range (ATR)
- MIRA 0.10
- AQMS 0.24
- MACD
- MIRA -0.02
- AQMS -0.01
- Stochastic Oscillator
- MIRA 24.29
- AQMS 14.16
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.